Charlotte's Web Holdings (CWBHF) Return on Capital Employed (2022 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Return on Capital Employed came in at 29.66% in Q1 2026, up 174.0% year-on-year from 10.83% in Q1 2025, and down 2.11% on a QoQ basis from 29.05% in Q4 2025.
Charlotte's Web Holdings (CWBHF) Return on Capital Employed (2022 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 5 years of Return on Capital Employed data on file, last reported at 29.66% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 174.0% year-over-year to 29.66% in Q1 2026; TTM through Mar 2026 was 29.66%, a 174.0% increase from a year earlier, with the FY2025 full-year figure at 23.65%, up 368.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 29.66%, down from 29.05% in the prior quarter.
- Over the last five years, Return on Capital Employed for CWBHF reached as high as 23.84% in Q2 2025 and fell as low as 103.78% in Q3 2022.
- Historically, Return on Capital Employed has averaged 44.6% across 5 years, with a median of 32.45% in 2024.
- Across the five-year window, Return on Capital Employed jumped 6832 bps in 2023 and sank 161 bps in 2024, its largest moves.
- Year by year, Return on Capital Employed stood at 36.79% in 2022, then increased by 18 bps to 30.18% in 2023, then decreased by 5 bps to 31.79% in 2024, then advanced by 9 bps to 29.05% in 2025, then declined by 2 bps to 29.66% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 29.66% in Q1 2026, 29.05% in Q4 2025, and 26.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -29.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.66% |
| Dec 31, 2025 | -29.05% |
| Sep 30, 2025 | -26.51% |
| Jun 30, 2025 | -23.84% |
| Mar 31, 2025 | -31.40% |
| Dec 31, 2024 | -31.79% |
| Sep 30, 2024 | -34.07% |
| Jun 30, 2024 | -36.50% |
| Mar 31, 2024 | -32.45% |
| Dec 31, 2023 | -30.18% |
| Sep 30, 2023 | -42.81% |
| Jun 30, 2023 | -35.28% |
| Mar 31, 2023 | -32.32% |
| Dec 31, 2022 | -36.79% |
| Sep 30, 2022 | -103.78% |
| Jun 30, 2022 | -103.60% |
| Mar 31, 2022 | -98.10% |